Our objective was to evaluate the association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus (T2DM) in the world population. We carried out a survey of the literature about the effect of rs12255372 on genetic susceptibility to T2DM by consulting PubMed, the Cochrane Library, and Embase from 2006 to 2012, and then performed a meta-analysis of all the studies in order to evaluate the association between rs12255372 and T2DM. A total of 33 articles including 42 studies (with 34,076 cases and 36,192 controls) were confirmed to be eligible and were included in the final meta-analysis: 6 studies conducted on Europeans, 14 on Caucasians, 17 on Asians, 2 on Africans, and 3 on Americans. Overall, the effect size was as follows: for the variant allele T (OR = 1.387, 95%CI = 1.351-1.424), for the TT genotype (OR = 1.933, 95%CI = 1.815-2.057), for the GT genotype (OR = 1.363, 95%CI = 1.315-1.413), for the dominant model (OR = 1.425, 95%CI = 1.344-1.510), and for the recessive model (OR = 1.659, 95%CI = 1.563-1.761). In summary, by pooling all available qualified data from genetic studies on rs12255372 and T2DM, we have confirmed that rs12255372 is significantly associated with susceptibility to T2DM in the global population.
Introduction
Type 2 diabetes mellitus (T2DM) represents the most common major form of diabetes, which results from a defect in insulin secretion, almost always with a major contribution from insulin resistance. The incidence and prevalence of T2DM have reached epidemic proportions all over the world. It is predicted that there will be at least 350 million people in the world with T2DM by the year 2030, unless appropriate action is taken (1) .
The mechanisms associated with T2DM have remained uncertain, but are considered to be due to a combination of lifestyle and genetic factors. Recently, research on genetic factors in T2DM has become more and more frequent and there is no doubt that the transcription factor 7-like 2 (TCF7L2) emerges as one of the strongest T2DM susceptibility genes among the possible candidate genes.
The TCF7L2 gene spans 215.9 kb on chromosome 10q25, and rs12255372, located in the intron region of TCF7L2, contains a single G to T base transition at position 293. A number of epidemiological studies have evaluated the association between rs12255372 and T2DM, but the results remain conflicting rather than conclusive (2-34; see Table 1 ). Two meta-analyses on the association between the TCF7L2 polymorphism rs12255372 and T2DM have been published (35, 36) . The first, published in 2009, detected significant associations between 4 single nucleotide polymorphisms (SNPs: rs7903146, rs12255372, rs7901695, and rs11196205) in TCF7L2 and T2DM all over the world (35) ; however, only articles published before 2008 were included. The second meta-analysis published in 2009 focused on the alleles on 5 SNPs (rs7903146, rs12255372, rs11196205, 
Research design and methods
Publication search A systematic search of the US National Library of Medicine's PubMed, the Cochrane Library, and Embase databases was conducted for all genetic association studies on rs12255372 in the TCF7L2 gene and T2DM published from 2006 [when the initial study reporting the association between rs12255372 and T2DM was published (31) ] to 2012. The language was limited to English. The following search terms were used in our metaanalysis: 'rs12255372', 'TCF7L2', 'T2DM/T2D', and 'genetic polymorphism'. 
Sladek (22) 
Inclusion criteria
We used the following criteria to select our literature: 1) original papers, 2) case-control studies, 3) studies that provided raw data for genotypic distribution or allele frequencies. A total of 41 papers were identified as potential candidates; 6 of them did not analyze rs12255372 and 2 did not concern the association between rs12255372 and T2DM and were excluded. Therefore, a total of 33 manuscripts were included in the final meta-analysis (2-34).
Data extraction
The following data were extracted independently from the articles by 2 of the authors (J. Wang and J. Zhang): first author's name, publication date, ethnicity, the sample size of cases and controls, allele frequencies, and numbers of each genotype.
Statistical analysis
To perform the meta-analysis, we used the METAN module within the STATA 11.0 software (USA). The strength of association between rs12255372 and the risk of T2DM was measured by odds ratios (ORs) with 95% confidence intervals (CI) via the Z-test. The heterogeneity index (I 2 , 0-100) was applied to assess heterogeneity among the studies (37) . If I 2 is above 50%, there is high heterogeneity between studies based on the Cochrane reviewer's handbook 4.2.2 (38) . The fixed-effect model with the Mantel-Haenszel method was applied if heterogeneity was not an issue in the studies (39) . Otherwise the random model using the DerSimonian and Laird method was used (40) . Subgroup analyses were performed according to ethnicity (European, Caucasian, Asian, African, and American). A funnel plot was constructed to display the potential publication bias, in which OR (in log units) was on the x-axis and the standard error of log OR was on the y-axis. If there is any publication bias, the funnel plot will support the presence of asymmetry. We assessed the funnel plot asymmetry by the Egger test. Sensitivity analysis was performed by omitting one study at a time and calculating the pooled ORs for the remaining studies.
Results
Description of the studies The electronic search yielded 41 potentially relevant articles on the association between rs12255372 and T2DM; however, only 33 papers including 42 studies met our inclusion criteria and were included in the final metaanalysis (2-34). Table 1 
Results of the meta-analysis

Subgroup analyses
Subgroup analysis by ethnicity showed that all genotypes were significantly associated with T2DM for Europeans, Caucasians, and Asians; the risk allele T and the recessive model of rs12255372 were associated with T2DM for the American population; neither genotype contributed to T2DM among Africans (see Table 2 ). The difference in ethnicity contributed to the heterogeneity. The studies on Caucasians involved more heterogeneity, Figure 1 . Meta-analysis of the association between type 2 diabetes and the risk allele T of rs12255372. with the complex compositions possibly being the main reason for this heterogeneity.
Publication bias
The funnel plot and the Egger test were performed to assess the publication bias of the literature. We displayed the funnel plot for ORs, and no evidence of obvious asymmetry was observed. All P values were higher than 0.05 according to the Egger test (see Table 3 ), and therefore no publication bias was found. Figure 6 presents Begg's funnel plots of publication bias.
Sensitivity analyses
We performed sensitivity analysis by omitting one study at a time and calculating the pooled ORs for the remaining studies. The results showed that none of the individual studies influenced the final conclusion. The sensitivity analysis indicated that our meta-analysis had reliable and stable results.
Discussion
TCF7L2 encodes an enteroendocrine transcription factor that controls the transcription of the proglucagon gene, which encodes both glucagon and glucagon-like peptide 1 (GLP-1). GLP-1 is a 30-amino acid peptide hormone produced by the intestinal epithelial endocrine Lcells by differential processing of proglucagon, the gene, which is expressed in these cells. The main actions of GLP-1 are to stimulate insulin secretion and to inhibit glucagon secretion, thereby contributing to limiting postprandial glucose excursions. Therefore, it has been suggested that polymorphisms in the TCF7L2 gene may affect the risk of T2DM by regulating the expression of GLP-1.
After a common microsatellite in the TCF7L2 gene region (DG10S478) was found to be associated with T2DM and this finding was convincingly replicated by Grant in 2006 (31) by using non-coding SNPs rs7903146, rs12255372, and rs11196205 that were in strong linkage disequilibrium with DG10S478, many other epidemiological study groups have detected a consistent association between these SNPs and T2DM in different ethnic populations including Japanese, Chinese, Americans, and Asian Indians. However, although the association between rs12255372 and T2DM has been evaluated by many research groups, the results remain conflicting rather than conclusive. These conflicting results indicated that a meta-analysis would be essential in order to validate the association between rs12255372 and T2DM.
Our meta-analysis included 33 papers for rs12255372; the results showed that the variant allele T, the TT genotype, the GT genotype, the dominant model, and the recessive model were all strongly associated with T2DM in the global population. Because the risk allele frequency of rs12255372 differed greatly among ethnicities (about 0.000 to 0.029 for Asians, 0.217-0.500 for Europeans, and 0.267-0.274 for Sub-Saharan Africans), we performed subgroup analyses according to ethnicity. The results suggested that the role of rs12255372 in T2DM may be mediated by ethnicity. For Europeans, Caucasians, and Asians, all genotypes and the risk allele T were significantly associated with T2DM, while for Americans, only the risk allele T and the recessive model could notably increase the risk of T2DM, suggesting that, although the risk allele T may increase the risk of incidence of T2DM, both copies of the mutant allele could achieve the goal, and a copy of the wild allele could be sufficient to provide protection. In contrast, for Africans, neither genotype contributed to the risk of T2DM. First, the differences in ethnicity and region may contribute to the strong heterogeneity of the genetic phenotype of T2DM. Second, the lack of original data in the studies reviewed limited our further evaluation of potential interactions of rs12255372 and T2DM, and confounders such as gender, age, and body mass index (BMI) may have contributed to the different results. Third, since studies on Africans were relatively rare in our metaanalysis, this may have reduced the power to detect an association of rs12255372 with T2DM in Africans.
In multiple ethnicities, the differences were reflected not only in the distributions of minor allele frequency in rs12255372 but also in the linkage disequilibrium (LD) structure between rs12255372 and rs7903146. Table 4 summarizes the pairwise LD coefficients r 2 and D' between these two SNPs in different populations based on the data from HapMap (HapMap Data Rel 27 PhaseII+ +III, Feb09, on NCBI B36 assembly, dbSNP b126). The results showed that rs12255372 and rs7903146 are in relatively strong LD in Europeans, and therefore the effect of rs12255372 is not independent. rs7903146 is known to be the strongest SNP for the risk of T2DM, and therefore the interaction between these two SNPs may be the key point for the association with T2DM. More representative and comprehensive studies on populations of different ethnic backgrounds are needed to clarify the mechanisms and underlying genetic effects of these two SNPs for T2DM in the global population. However, due to the really weak LD structure between them, and coupled to the lower minor allele frequency, the effect of rs12255372 for the risk of T2DM in Sub-Saharan Africans and East Asians was quite small. Hardy-Weinberg equilibrium is a principle showing how representative the samples are. Violations of HardyWeinberg assumptions can cause deviations from expectation. In our 33 eligible articles, the genotypes in both cases and controls almost conformed to the HardyWeinberg principle.
Heterogeneity is a potential problem when interpreting the results of meta-analysis. Our meta-analysis revealed high heterogeneity between studies for the dominant model (I 2 .50%). By subgroup analysis, we found that studies focusing on Caucasians exhibited more heterogeneity because of their complex composition. The differences in gender, age, and BMI among the studies, and the quality of the articles might also contribute to the heterogeneity.
Some limitations of this meta-analysis should be acknowledged. Because of the absence of detailed information about BMI, age, and gender in some studies, we did our research based on single-factor estimates without adjustment for the other risk factors mentioned above. On the other hand, our study also showed some strengths. First, the sample sizes of the studies included were relatively large, possibly reducing the influence of the low allele frequency. Second, our meta-analysis showed much better homogeneity, suggesting the uniform composition or character of our studies. Third, no publication bias was found in our meta-analysis by the funnel plot and the Egger test.
In summary, in this meta-analysis, by pooling all available qualified data of genetic studies on rs12255372 and T2DM, we confirmed that rs12255372 was significantly associated with susceptibility to T2DM in the global population, the risk allele and the genotypes could increase the risk of T2DM from 1.363-to 1.933-fold. 
